{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:31:02Z","timestamp":1768548662093,"version":"3.49.0"},"posted":{"date-parts":[[2021,1,27]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":28,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  The SARS-CoV-2 pandemic and the vaccination effort that is ongoing has created an unmet need for accessible, affordable, flexible and precise platforms for monitoring the induction, specificity and maintenance of virus-specific immune responses. Herein we validate a multiplex (Luminex-based) assay capable of detecting SARS-CoV-2-specific antibodies irrespective of host species, antibody isotype, and specimen type (e.g. plasma, serum, saliva or blood spots). The well-established precision of Luminex-based assays provides the ability to follow changes in antibody levels over time to many antigens, including multiple permutations of the most common SARS-CoV-2 antigens. This platform can easily measure antibodies known to correlate with neutralization activity as well as multiple non-SARS-CoV-2 antigens such as vaccines (\n                  <jats:italic>e<\/jats:italic>\n                  .\n                  <jats:italic>g<\/jats:italic>\n                  . Tetanus toxoid) or those from frequently encountered agents (influenza), which serve as stable reference points for quantifying the changing SARS-specific responses. All of the antigens utilized in our study can be made in-house, many in\n                  <jats:italic>E. coli<\/jats:italic>\n                  using readily available plasmids. Commercially sourced antigens may also be incorporated and newly available antigen variants can be rapidly produced and integrated, making the platform adaptable to the evolving viral strains in this pandemic.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Brief Summary<\/jats:title>\n                  <jats:p>A multi-antigen assay for monitoring SARS-CoV-2-specific antibodies irrespective of host species, antibody isotype, and specimen type was developed.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2021.01.20.21249279","type":"posted-content","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T10:55:48Z","timestamp":1611744948000},"source":"Crossref","is-referenced-by-count":3,"title":["A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses"],"prefix":"10.64898","author":[{"given":"Huifeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Forgacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digantkumar","family":"Chapla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley W.","family":"Moremen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srilatha","family":"Edupuganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick L.","family":"Tarleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021012909450867000_2021.01.20.21249279v1.1","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fimmu.2018.01958","article-title":"Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes","volume":"9","year":"2018","journal-title":"Frontiers in immunology"},{"key":"2021012909450867000_2021.01.20.21249279v1.2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3389\/fimmu.2017.01141","article-title":"The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects","volume":"8","year":"2017","journal-title":"Frontiers in immunology"},{"issue":"10","key":"2021012909450867000_2021.01.20.21249279v1.3","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1371\/journal.pntd.0000316","article-title":"High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection","volume":"2","year":"2008","journal-title":"PLoS neglected tropical diseases"},{"key":"2021012909450867000_2021.01.20.21249279v1.4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1297-9716-45-6","article-title":"Frequency of IFNgamma-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection","volume":"45","year":"2014","journal-title":"Vet Res"},{"key":"2021012909450867000_2021.01.20.21249279v1.5","doi-asserted-by":"publisher","DOI":"10.1086\/648072"},{"key":"2021012909450867000_2021.01.20.21249279v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks390"},{"issue":"9","key":"2021012909450867000_2021.01.20.21249279v1.7","doi-asserted-by":"crossref","first-page":"e1314","DOI":"10.1371\/journal.pntd.0001314","article-title":"Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease","volume":"5","year":"2011","journal-title":"PLoS neglected tropical diseases"},{"issue":"10","key":"2021012909450867000_2021.01.20.21249279v1.8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","article-title":"ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection","volume":"21","year":"2020","journal-title":"Nature immunology"},{"issue":"1","key":"2021012909450867000_2021.01.20.21249279v1.9","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1038\/s41467-020-19967-4","article-title":"Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates","volume":"11","year":"2020","journal-title":"Nature communications"},{"key":"2021012909450867000_2021.01.20.21249279v1.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008903"},{"key":"2021012909450867000_2021.01.20.21249279v1.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010817117"},{"issue":"7831","key":"2021012909450867000_2021.01.20.21249279v1.12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-020-2334-5","article-title":"Infection of dogs with SARS-CoV-2","volume":"586","year":"2020","journal-title":"Nature"},{"key":"2021012909450867000_2021.01.20.21249279v1.13","doi-asserted-by":"crossref","unstructured":"Hamer SA , et al. Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas, USA. bioRxiv. 2020:2020.2012.2008.416339.","DOI":"10.1101\/2020.12.08.416339"},{"issue":"4","key":"2021012909450867000_2021.01.20.21249279v1.14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","year":"2020","journal-title":"Cell"},{"key":"2021012909450867000_2021.01.20.21249279v1.15","unstructured":"Shrock E , et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science. 2020."},{"key":"2021012909450867000_2021.01.20.21249279v1.16","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.jcv.2020.104521","article-title":"Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV","volume":"129","year":"2020","journal-title":"J Clin Virol"},{"key":"2021012909450867000_2021.01.20.21249279v1.17","doi-asserted-by":"crossref","unstructured":"Cameron A , et al. A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization. Journal of clinical microbiology. 2020.","DOI":"10.1101\/2020.10.05.20203976"},{"key":"2021012909450867000_2021.01.20.21249279v1.18","doi-asserted-by":"crossref","unstructured":"Chen JH , et al. Clinical Performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 Detection in Nasopharyngeal Specimens from COVID-19 Patients in Hong Kong. Journal of clinical microbiology. 2020;58(8).","DOI":"10.1128\/JCM.00936-20"},{"key":"2021012909450867000_2021.01.20.21249279v1.19","doi-asserted-by":"crossref","unstructured":"Dobano C , et al. Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A and G against SARS-CoV-2 antigens. Journal of clinical microbiology. 2020.","DOI":"10.1101\/2020.06.11.147363"},{"key":"2021012909450867000_2021.01.20.21249279v1.20","first-page":"114025","article-title":"Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay","volume":"288","year":"2020","journal-title":"J Virol Methods"},{"key":"2021012909450867000_2021.01.20.21249279v1.21","doi-asserted-by":"crossref","unstructured":"Moncunill G , et al. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after three months of follow-up. The Journal of infectious diseases. 2020.","DOI":"10.1093\/infdis\/jiaa696"},{"key":"2021012909450867000_2021.01.20.21249279v1.22","doi-asserted-by":"crossref","unstructured":"Pisanic N , et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. Journal of clinical microbiology. 2020.","DOI":"10.1128\/JCM.02204-20"},{"issue":"10","key":"2021012909450867000_2021.01.20.21249279v1.23","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jiaa531","article-title":"A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2","volume":"222","year":"2020","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"2021012909450867000_2021.01.20.21249279v1.24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","year":"2020","journal-title":"Nature medicine"},{"issue":"1","key":"2021012909450867000_2021.01.20.21249279v1.25","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","year":"2020","journal-title":"Current protocols in microbiology"},{"issue":"4","key":"2021012909450867000_2021.01.20.21249279v1.26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor","volume":"28","year":"2020","journal-title":"Cell host & microbe"},{"issue":"2","key":"2021012909450867000_2021.01.20.21249279v1.27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nchembio.2539","article-title":"Expression system for structural and functional studies of human glycosylation enzymes","volume":"14","year":"2018","journal-title":"Nature chemical biology"},{"key":"2021012909450867000_2021.01.20.21249279v1.28","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-195"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.01.20.21249279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:03:57Z","timestamp":1768485837000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.01.20.21249279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1101\/2021.01.20.21249279","relation":{},"subject":[],"published":{"date-parts":[[2021,1,27]]},"subtype":"preprint"}}